Encision Inc. (ECIA:PK), a medical device company owning patented surgical technology that prevents stray electrosurgical burns in minimally invasive surgery, today announced the appointment of Greg Trudel as its new President and CEO. A proven manager with over 25 years of experience in the surgical devices marketplace, Mr. Trudel will assume his new duties at Encision on December 23.
"Greg brings a legacy of success in the surgical device market to Encision," said Patrick W. Pace, MD, Executive Chairman of Encision.
"His deep operational experience and exceptional track record in sales and marketing will provide a fresh energy and culture to drive our patented AEM technology to future success." Prior to joining Encision, Greg served as Global Director of Marketing for a division within the Surgical Solutions Group at Covidien. His time at Covidien also includes extensive experience in both the Advanced Energy and Surgical Stapling Divisions. Prior to joining Covidien, Greg held leadership roles with ConMed Electrosurgery, SilverGlide Surgical Technologies, and Stryker. He holds a B.S. from the University of Connecticut, Storrs, CT and an M.B.A from the University of Bridgeport, Bridgeport, CT.
Encision Inc. designs, develops, manufactures and markets innovative surgical devices that allow surgeons to optimize technique and patient safety during a broad range of surgical procedures. Based in Boulder, Colorado, the Company pioneered the development of patented AEM@ Laparoscopic Instruments to improve electrosurgery and reduce the chance for patient injury in minimally invasive surgery.